Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*Sophie Georgin‐Lavialle, Thomas Cluzeau, Samuel Ardois et al.|British Journal of Dermatology|2021Cited by 414
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Benjamin Terrier, Céline Posseme et al.|Nature Communications|2024Cited by 87
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin De Valence, Mikaël Ebbo, M. Delaune et al.|Annals of the Rheumatic Diseases|2023Cited by 70
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, C. Deligny, Loula Papageorgiou et al.|Journal of the American Academy of Dermatology|2022Cited by 67